reviewNature Reviews Drug DiscoveryFeb 9, 2007Closed access

A decade of fragment-based drug design: strategic advances and lessons learned

PJPhilip J. Hajduk JGJonathan Greer

Discovery Laboratories (United States) · Abbott (United States)

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,045

total citations

FWCI: 94.97
Percentile: 100%
References: 77

Citations per year

Authors

2

PJ
Philip J. HajdukCorresponding
Discovery Laboratories (United States), Abbott (United States)
JG
Jonathan Greer
Abbott (United States), Discovery Laboratories (United States)

Topics & keywords

Topics

Keywords

Fragment (logic)
Drug discovery
Pharmaceutical industry
Drug
Investment (military)
Risk analysis (engineering)
Business
Computational biology

No related works found for this paper.